Page 102 - Biennial Report 2018-20 Jun 2021

104. Iqbal B, Ali J, Ganguli M, Mishra S, Baboota S. “Silymarin-loaded nanostructured lipid
carrier gel for the treatment of skin cancer. (Short Communication)” NANOMEDICINE-
UK 2019 May;14(9):1077-1093.
105. Meena S and Meena LS. “Mycobacterial polymerases: A possible drug target for TB
treatment (Review Article).” Current Res Bio Mol Biol. 2019. 2019 : 1(1) 6-9.

106. Bisht D, Meena LS. “Adhesion molecules facilitate host-pathogen interaction & mediate
Mycobacterium tuberculosis pathogenesis (Review Article).” INDIAN J MED RES 2019
Jul;150(1):23-32.

107. GUaRDIAN Consortium, Sivasubbu S, Scaria V. “Genomics of rare genetic diseases-
experiences from India (Review).” HUM GENOMICS 2019 Sep 25;14(1):52.
108. Faruq M, Kumar D, Wadhwa S, Shamim U, Mathur A, Parveen S, Garg A, Srivastava AK.
“Intrafamilial variable spastic paraplegia/ataxia/ALS phenotype linked to a novel KIF5A
mutation (Letter To The Editor).” CLIN GENET 2019 Sep;96(3):271-273.
109. Kickbusch I, Agrawal A, Jack A, Lee N, Horton R. “Governing health futures 2030: growing
up in a digital world-a joint The Lancet and Financial Times Commission. (Comment)”
LANCET 2019 Oct 12;394(10206):1309.
110. Shivangi, Meena LS. “A Repurposing Approach To Target The Pi3 Kinase Pathway Of
Mycobacterium Tuberculosis H37rv By Heavy Metal Ions. (Short Communication)” Res
Rev J Microbiol Biotechnol. 2019 Oct, 8(3), 37-44.

111. Tanwar P, Shivangi, Meena LS. “Cholesterol Metabolism: As a Promising Target
Candidate for Tuberculosis Treatment by Nanomedicine. (Review)” J Nanomater Mol
Nanotech. 2019 Nov, 8:4, 1000273, 1-8.

112. Ramalingam S, Thangavel S. “CRISPR-Cas9 Probing of Infectious Diseases and Genetic
Disorders (Review Article).” INDIAN J PEDIATR 2019 Dec;86(12):1131-1135.
113. Mulchandani R, Chandrasekaran AM, Shivashankar R, Kondal D, Agrawal A,
Panniyammakal J, Tandon N, Prabhakaran D, Sharma M, Goenka S. “Effect of workplace
physical activity interventions on the cardio-metabolic health of working adults:
systematic review and meta-analysis. (Review)” INT J BEHAV NUTR PHY 2019 Dec
19;16(1):134.

114. Gupta M, Shivangi, Meena LS. “Understanding the Machinery of Mycobacteriophage to
Control Infection of Mycobacterium tuberculosis H37Rv Using Mycobacterium
Smegmatis. (Review Article)” Arch Nanomed. 2019 Dec, 2(2); 170-175.
115. Jatana N, Aswin SK, Rathore S, Thukral L. “Revealing Conformational Transitions in G-
Protein-Coupled Receptor Rhodopsin upon Phosphorylation. (Communication)”
BIOCHEMISTRY-US 2020, 59, 297-302.
116. Loganathan L, Gopinath K, Sankaranarayanan VM, Kukreti R, Rajendran K, Lee JK,
Muthusamy K. “Computational and Pharmacogenomic Insights on Hypertension
Treatment: Rational Drug Design and Optimization Strategies. (Review)” CURR DRUG
TARGETS 2020;21(1):18-33.
117. Yadav S, Sharma AK, Kumar P. “Nanoscale Self-Assembly for Therapeutic Delivery.
(Review)” FRONT BIOENG BIOTECH 2020 Feb 25;8:127.

101